Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,132,344
-
Share change
-
+279,123
-
Total reported value
-
$43,241,915
-
Price per share
-
$20.28
-
Number of holders
-
37
-
Value change
-
+$11,831,067
-
Number of buys
-
23
-
Number of sells
-
21
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q4 2022
As of 31 Dec 2022,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,132,344 shares.
The largest 10 holders included
Western Standard LLC, Apis Capital Advisors, LLC, MORGAN STANLEY, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, DIMENSIONAL FUND ADVISORS LP, NEW YORK LIFE INVESTMENT MANAGEMENT LLC, CSS LLC/IL, and Parkman Healthcare Partners LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.